Orthofix International (OFIX) – Company Press Releases
-
Orthofix Names Andres Cedron as New Chief Legal Officer
-
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
-
Orthofix Reports Fourth Quarter and Full Year 2023 Results
-
Orthofix Announces New President for Bone Growth Therapies Business
-
Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024
-
Orthofix Announces Commercial Partnership with MRIguidance
-
Julie Andrews Begins as New Chief Financial Officer at Orthofix
-
Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
-
Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
-
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis
-
Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company
-
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
-
Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
-
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
-
Lowey Dannenberg, P.C. is Investigating Orthofix Medical Inc. (NASDAQ: OFIX) for Potential Breaches of Fiduciary Duty by Its Board of Directors
-
Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc
-
Orthofix Names Massimo Calafiore as President and Chief Executive Officer
-
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
-
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
-
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
-
Orthofix Reports Third Quarter 2023 Results
-
Orthofix Announces Full Commercial Launch of the WaveForm L Interbody System for Lateral Lumbar Fusion Procedures
-
ORTHOFIX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Op
-
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, Dollar, and Clorox and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Is Investigating Viasat, Veradigm, and Orthofix and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Scynexis and Encourages Investors to Contact the Firm
-
Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 8, 2023
-
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Dollar and Encourages Investors to Contact the Firm
-
Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures
-
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Dollar and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Scynexis and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Is Investigating FMC, and Orthofix and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Is Investigating Lovesac, and Orthofix and Encourages Investors to Contact the Firm
-
Orthofix Announces First Patient Procedures and Full Commercial Launch of the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma Procedures
-
Bragar Eagel & Squire, P.C. Is Investigating Veradigm, Holley, and Orthofix and Encourages Investors to Contact the Firm
-
Orthofix Announces Leadership Changes
-
Orthofix to Participate in Morgan Stanley Healthcare Conference
-
Orthofix Announces First Cases and Full Commercial Launch of the 7D FLASH Navigation System Percutaneous Module 2.0 for Minimally Invasive Surgery
-
Orthofix Medical to Host Investor Day on September 20, 2023
-
Orthofix Reports Second Quarter 2023 Results and Raises Revenue and Adjusted EBITDA Guidance
-
Orthofix Schedules Second Quarter Earnings Release and Conference Call for August 8, 2023, and Announces Participation in Upcoming Investor Conference
-
Orthofix Introduces New Phantom and Tornado Hinges for TrueLok Ring Fixation Systems
-
Orthofix Announces Changes to Board of Directors
-
Orthofix Announces the Full Commercial Launch of WaveForm A 3D Printed Anterior Lumbar Interbody
-
Orthofix Announces First Presentation of Seven-Year Outcome Data for the M6-C Artificial Cervical Disc With Other Clinical and Scientific Abstracts at the ISASS Annual Meeting
-
Orthofix Reports First Quarter 2023 Results
-
MedTech Breakthrough Recognizes STIM onTrack for Bone Growth Therapy as Best Patient Engagement Mobile App
-
Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 9, 2023
-
Orthofix Expands Solutions for Minimally Invasive Spine Procedures with the Full Commercial Launch of Two Access Retractor Systems
Back to OFIX Stock Lookup
